119 related articles for article (PubMed ID: 17409954)
1. Novel cytotoxic agents for non-small cell lung cancer.
Edelman MJ
J Thorac Oncol; 2006 Sep; 1(7):752-5. PubMed ID: 17409954
[TBL] [Abstract][Full Text] [Related]
2. Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer.
Edelman MJ
Clin Lung Cancer; 2009 Mar; 10 Suppl 1():S30-4. PubMed ID: 19362944
[TBL] [Abstract][Full Text] [Related]
3. Novel taxanes/epothilones.
Dy G
J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S490-1. PubMed ID: 21102252
[No Abstract] [Full Text] [Related]
4. Epothilones in development for non--small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistance.
Edelman MJ; Shvartsbeyn M
Clin Lung Cancer; 2012 May; 13(3):171-80. PubMed ID: 22133291
[TBL] [Abstract][Full Text] [Related]
5. The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer.
Sève P; Reiman T; Dumontet C
Lung Cancer; 2010 Feb; 67(2):136-43. PubMed ID: 19828208
[TBL] [Abstract][Full Text] [Related]
6. New developments in chemotherapy for advanced non-small cell lung cancer.
Raez LE; Lilenbaum R
Curr Opin Oncol; 2006 Mar; 18(2):156-61. PubMed ID: 16462185
[TBL] [Abstract][Full Text] [Related]
7. Taxane- and epothilone-based chemotherapy: from molecule cargo cytoskeletal logistics to management of castration-resistant prostate carcinoma.
Alberti C
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1658-64. PubMed ID: 23832735
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-tubulin cytotoxic agents for breast cancer.
Morris PG; Fornier MN
Expert Rev Anticancer Ther; 2009 Feb; 9(2):175-85. PubMed ID: 19192956
[TBL] [Abstract][Full Text] [Related]
9. Activity of novel cytotoxic agents in lung cancer: epothilones and topoisomerase I inhibitors.
Wakelee HA; Sikic BI
Clin Lung Cancer; 2005 Sep; 7 Suppl 1():S6-12. PubMed ID: 16159420
[TBL] [Abstract][Full Text] [Related]
10. New anti-tubulin agents.
Felip E
Suppl Tumori; 2002; 1(4):S17-8. PubMed ID: 12415808
[No Abstract] [Full Text] [Related]
11. Taxanes, past, present, and future impact on non-small cell lung cancer.
Joshi M; Liu X; Belani CP
Anticancer Drugs; 2014 May; 25(5):571-83. PubMed ID: 24463482
[TBL] [Abstract][Full Text] [Related]
12. Ixabepilone and the narrow path to developing new cytotoxic drugs.
Gianni L
J Clin Oncol; 2007 Aug; 25(23):3389-91. PubMed ID: 17606970
[No Abstract] [Full Text] [Related]
13. Current perspectives of epothilones in breast cancer.
Cardoso F; de Azambuja E; Lago LD
Eur J Cancer; 2008 Feb; 44(3):341-52. PubMed ID: 18178426
[TBL] [Abstract][Full Text] [Related]
14. Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors.
Rivera E; Lee J; Davies A
Oncologist; 2008 Dec; 13(12):1207-23. PubMed ID: 19088324
[TBL] [Abstract][Full Text] [Related]
15. The epothilones: how pharmacology relates to clinical utility.
Michaud LB
Ann Pharmacother; 2009 Jul; 43(7):1294-309. PubMed ID: 19584389
[TBL] [Abstract][Full Text] [Related]
16. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
Cortes J; Baselga J
Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
Xie CY; Xu YP; Jin W; Lou LG
Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
[TBL] [Abstract][Full Text] [Related]
18. Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes.
Yardley DA
Clin Breast Cancer; 2008 Dec; 8(6):487-92. PubMed ID: 19073502
[TBL] [Abstract][Full Text] [Related]
19. Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms.
Vahdat L
Oncologist; 2008 Mar; 13(3):214-21. PubMed ID: 18378531
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin status.
Edelman MJ; Schneider CP; Tsai CM; Kim HT; Quoix E; Luft AV; Kaleta R; Mukhopadhyay P; Trifan OC; Whitaker L; Reck M
J Clin Oncol; 2013 Jun; 31(16):1990-6. PubMed ID: 23589560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]